Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: nab-paclitaxel followed by anthracycline and cyclophosphamide|DRUG: Docetaxel followed by anthracycline and cyclophosphamide
Sponsor: Xijing Hospital